Connor, Clark & Lunn Investment Management (CC&L)’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-42,133
Closed -$2.69M 1574
2025
Q1
$2.69M Buy
42,133
+1,185
+3% +$68.8K 0.01% 657
2024
Q4
$1.96M Buy
+40,948
New +$2.1M 0.01% 732
2024
Q3
Sell
-37,082
Closed -$1.94M 1526
2024
Q2
$1.94M Buy
+37,082
New +$1.63M 0.01% 664
2024
Q1
Sell
-159,242
Closed -$5.89M 1597
2023
Q4
$5.89M Sell
159,242
-13,866
-8% -$522K 0.03% 379
2023
Q3
$6.61M Buy
173,108
+62,628
+57% +$2.57M 0.03% 328
2023
Q2
$3.99M Sell
110,480
-22,728
-17% -$775K 0.02% 440
2023
Q1
$5.09M Buy
133,208
+27,669
+26% +$1.3M 0.03% 366
2022
Q4
$6.01M Buy
+105,539
New +$5.4M 0.03% 320
2022
Q3
Sell
-37,513
Closed -$1.65M 1164
2022
Q2
$1.65M Buy
+37,513
New +$1.62M 0.01% 509
2021
Q1
Sell
-5,332
Closed -$228K 1025
2020
Q4
$228K Buy
+5,332
New +$192K ﹤0.01% 816
2017
Q3
Sell
-11,625
Closed -$149K 853
2017
Q2
$149K Buy
+11,625
New +$155K ﹤0.01% 768
2014
Q2
Sell
-20,110
Closed -$282K 576
2014
Q1
$282K Buy
20,110
+8,704
+76% +$129K ﹤0.01% 582
2013
Q4
$182K Sell
11,406
-216,894
-95% -$2.79M ﹤0.01% 671
2013
Q3
$2.59M Buy
+228,300
New +$1.9M 0.02% 172

Other funds holding HALO

Connor, Clark & Lunn Investment Management (CC&L)'s HALO Position: Q2 2025 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of Halozyme (HALO) in Q2 2025, closing a stake of 42,133 shares — an estimated $2.69M sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in HALO in Q3 2013 and held it in 14 quarters. The position peaked at $6.61M in Q3 2023. 551 funds tracked by Wall St. Rank hold HALO as of Q2 2025.

  • Connor, Clark & Lunn Investment Management (CC&L) reported no remaining Halozyme position as of Q2 2025 after selling out during the quarter.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 42,133 Halozyme shares in Q2 2025, an estimated $2.69M.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Halozyme in Q3 2013 and held it in 14 quarters.
  • Connor, Clark & Lunn Investment Management (CC&L)'s Halozyme position peaked at $6.61M in Q3 2023.
  • 551 funds tracked by Wall St. Rank held Halozyme as of Q2 2025.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q2 2025, filed 7 Aug 2025.